BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:COR-1004 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of COR-1004\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07229118-8311@assetmemo.bio
DTSTAMP:20261121T004543Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:COR-1004: Phase 1 readout est. (NCT07229118)
DESCRIPTION:COR-1004\, phase 1\, Atherosclerotic Cardiovascular Disease.\nS
 tudy: A Study to Evaluate COR-1004 in Adult Volunteers.\nEstimated primary
  completion: February 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/cor-1004#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT07229118
URL:https://assetmemo.bio/drug/cor-1004#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07858019-8311@assetmemo.bio
DTSTAMP:20261121T004543Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:COR-1004: Phase 1 readout est. (NCT07858019)
DESCRIPTION:COR-1004\, phase 1\, Atherosclerotic Cardiovascular Disease.\nS
 tudy: A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With
  COR-1004 in Adult Volunteers\nEstimated primary completion: August 2027. 
 This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and
  it can move.\nDrug page: https://assetmemo.bio/drug/cor-1004#upcoming-eve
 nts\nRegistry record: https://clinicaltrials.gov/study/NCT07858019
URL:https://assetmemo.bio/drug/cor-1004#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
